HENDERSON JANE (Chief Financial Officer) sold 1.1% of their position (2K shares) of APOGEE THERAPEUTICS, INC. on the open market
Open‑market sale worth $164.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 5/5/2026ACC: 0001104659-26-055091
Officer· Chief Financial Officer
Since Mar 2026
-2K
Net shares
Net seller
$164.1K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
2K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−811.00
Price / share
$81.02
Trade value
$65.71K
% of position
0.5%
5/1/2026
175.37K→174.56K
Common Stock
Direct
Shares
−900.00
Price / share
$82.60
Trade value
$74.34K
% of position
0.5%
5/1/2026
174.56K→173.66K
Common Stock
Direct
Shares
−289.00
Price / share
$83.16
Trade value
$24.03K
% of position
0.2%
5/1/2026
173.66K→173.37K
Total
Net shares
−2K
Net value
-$164.08K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −811.00 | $81.02 | $65.71K | 0.5% | 175.37K | 174.56K |
| Common Stock Direct | 5/1/2026 | S · Sale | −900.00 | $82.60 | $74.34K | 0.5% | 174.56K | 173.66K |
| Common Stock Direct | 5/1/2026 | S · Sale | −289.00 | $83.16 | $24.03K | 0.2% | 173.66K | 173.37K |
| Total | −2K | -$164.08K | ||||||
Derivative Transactions0
No derivative transactions reported